Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT07460986
Recruiting
A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma.
Phase 1/2 · Spain · 12 sites
Registry update: 31 Aug 2026
NCT07650656
Recruiting
Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial
Phase 2 · United States · 1 site
Registry update: 16 Oct 2026
NCT07713732
Recruiting
TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors
Phase 1 · Australia · 3 sites
Registry update: 1 Oct 2026
NCT05253131
Recruiting
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
Phase 2 · United States · 1 site
Registry update: 24 Aug 2026
NCT07549022
Recruiting
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor
Phase 1/2 · United States · 1 site
Registry update: 11 Aug 2026
NCT07662239
Recruiting
Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention
Not applicable · United States · 3 sites
Registry update: 26 Aug 2026
NCT07658768
Recruiting
Pilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric Patients
Early phase 1 · United States · 1 site
Registry update: 2 Nov 2026
NCT07507773
Recruiting
Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall
Phase 2 · France · 1 site
Registry update: 23 Jul 2026
NCT07727434
Recruiting
Stress and Anxiety Before Biopsy, After Biopsy Results, and During Treatment in Patients With Suspected Bone or Soft Tissue Cancer
Not applicable · 1 site
Registry update: 27 Jul 2026
NCT07725380
Recruiting
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Phase 1/2 · United States · 4 sites
Registry update: 3 Sept 2026
NCT07211737
Recruiting
NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma
Phase 1 · United States · 1 site
Registry update: 21 Jul 2026
NCT07466316
Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Phase 3 · Canada, United States · 87 sites
Registry update: 25 Aug 2026
NCT07878364
Recruiting
Treatment Patterns and Survival Outcomes in High-Grade Osteosarcoma: A Multicenter Retrospective Study
Not applicable · South Korea · 4 sites
Registry update: 16 Oct 2026
2025-523997-18-00
Recruiting
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
Phase 1/2 · France · 3 sites
Registry update: 27 Jul 2026
NCT07705334
Recruiting
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Phase 1 · United States · 3 sites
Registry update: 22 Oct 2026
NCT07630961
Recruiting
Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
Phase 1 · Denmark, Japan · 2 sites
Registry update: 27 Aug 2026
NCT07602777
Recruiting
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
Phase 1/2 · Canada, France, United Kingdom, Israel, Japan, United States · 13 sites
Registry update: 1 Oct 2026
2024-514089-37-00
Recruiting
Indocyanine Green and near infrared fLuorescence in paediatric Oncology surgery
Phase 2 · Netherlands · 1 site
Registry update: 30 Apr 2026
NCT07502885
Recruiting
Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients
Not applicable · United States · 1 site
Registry update: 18 Jun 2026
NCT07444619
Recruiting
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
Phase 1 · United States · 1 site
Registry update: 6 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.